Pfizer
Institution Profile
Recognized for Excellence As a Med Honors Top Pharmaceutical Innovator, Pfizer has played a pivotal role in advancing modern medicine through cutting-edge drug development, vaccine innovation, and biopharmaceutical research. Founded in 1849, Pfizer has grown into one of the world's most influential pharmaceutical companies, delivering life-changing therapies across multiple specialties. Pfizer is widely known for its groundbreaking work in vaccine development, particularly its mRNA-based COVID-19 vaccine, developed in partnership with BioNTech. As the first FDA-approved mRNA vaccine, it revolutionized global efforts to combat the pandemic and reinforced Pfizer's position as a leader in infectious disease prevention, building on a legacy that includes vaccines for pneumococcal disease, meningitis, and influenza. Beyond vaccines, Pfizer is a driving force in oncology, immunology, and cardiovascular medicine, consistently introducing best-in-class therapies. Its oncology portfolio includes Ibrance (palbociclib), a leading treatment for metastatic breast cancer, as well as Bavencio (avelumab) and Lorbrena (lorlatinib), which have expanded treatment options for difficult-to-treat cancers. In immunology, Xeljanz (tofacitinib) has transformed care for autoimmune conditions such as rheumatoid arthritis and ulcerative colitis, while Eliquis (apixaban) remains a cornerstone of stroke prevention and cardiovascular health. With a relentless commitment to research and innovation, Pfizer continues to develop groundbreaking therapies that shape the future of medicine, earning its place among Med Honors' most distinguished pharmaceutical leaders.
Profile last updated: July 9, 2026
2026 TOP PHARMACEUTICAL INNOVATORS
Pfizer
Also Featured
